Search Results - Xiaodan Lai
- Showing 1 - 2 results of 2
-
1
Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system by Rui Xiong, Jing Lei, Sicen Pan, Hong Zhang, Yongtao Tong, Wei Wu, Yi Huang, Xiaodan Lai
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example by Rui Xiong, Jing Lei, Lu Wang, Shipeng Zhang, Hengxu Liu, Hongping Wang, Tao Liu, Xiaodan Lai
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book